Monthly Archives: February 2012

“The Truly Staggering Cost Of Inventing New Drugs”

Another provocative piece in Forbes  that implies the cost of developing a new drug could be as high as $12B!!  This approach has a number of flaws (as does: “Best Drug Companies.. “)  All produce (provoke?) some interesting insights from commenters.    Funny how … Continue reading

Posted in Uncategorized | Leave a comment

 

Share

“The Best Drug Companies Of The Past 15 Years?”

Matt Herper in Forbes’ “the Medicine Show” posts a point of view by Bernard Munos on what firms have done best in terms of approved drugs since 1995.  The link is here (http://onforb.es/zb6xgu), as are my comments on this provocative topic.  … Continue reading

Posted in Core Learnings, Financial, In the Pipeline | 1 Comment

 

Share